Back to
RENAISSANCE TECHNOLOGIES LLC
LYEL5 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in LYELL IMMUNOPHARMA INC
Yes. Renaissance Technologies holds 130,190 shares of LYEL (Lyell Immunopharma), worth $1.8M, as of its Q2 2026 13F filing. It increased the position by 13,779 shares (+11.8%) from Q1 2026. Renaissance Technologies has held LYEL in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$1.8M
Current Shares
130,190
Total Value Change
+$1.2M
Total Shares Change
+63,000
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.